These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6326216)

  • 1. Failure to induce stress reactions following vaccination against Marek's disease or Newcastle disease.
    Freeman BM; Manning AC
    Res Vet Sci; 1984 Mar; 36(2):247-50. PubMed ID: 6326216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experiments with the simultaneous or combined vaccination of chicks against Marek's disease and Newcastle disease].
    Cholakova R; Stanilov Kh; Aleksiev N
    Vet Med Nauki; 1978; 15(7):19-26. PubMed ID: 219586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
    Gagic M; St Hill CA; Sharma JM
    Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological changes in chickens inoculated with reticuloendotheliosis-virus-contaminated Marek's disease vaccine.
    Taniguchi T; Yuasa N; Sato S; Horiuchi T
    Natl Inst Anim Health Q (Tokyo); 1977; 17(4):141-50. PubMed ID: 203872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the heterophil/lymphocyte ratio as a measure of stress in chickens.
    Gross WB; Siegel HS
    Avian Dis; 1983; 27(4):972-9. PubMed ID: 6360120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonspecific innate immunity against Escherichia coli infection in chickens induced by vaccine strains of Newcastle disease virus.
    Huang HJ; Matsumoto M
    Avian Dis; 2000; 44(4):790-6. PubMed ID: 11195632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term stressor effects of propranolol.
    Freeman BM; Manning AC
    Br Poult Sci; 1980 Jan; 21(1):55-9. PubMed ID: 7397592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity to infectious bronchitis in broilers vaccinated against Marek's disease either in ovo or at hatch and against infectious bronchitis at hatch.
    Avakian AP; Wakenell PS; Grosse D; Whitfill CE; Link D
    Avian Dis; 2000; 44(3):536-44. PubMed ID: 11007000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of repeated injections of adrenaline on the response of the fowl to further alarm stimulation.
    Freeman BM; Manning AC
    Res Vet Sci; 1979 Jul; 27(1):76-81. PubMed ID: 504809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of chicken spleen cell mitogenic response with turkey herpesvirus vaccine against Marek's disease.
    Benda V; Vilhelmová M; Hála K
    Folia Biol (Praha); 1978; 24(3):210-4. PubMed ID: 208875
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
    Bacon LD; Witter RL
    Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of Marek's disease using 3 vaccines in chickens belonging to different genetic varieties of meat producers].
    Picault JP; Guittet M; Bennejean G; Goater E
    Dev Biol Stand; 1982; 52():447-53. PubMed ID: 6299854
    [No Abstract]   [Full Text] [Related]  

  • 20. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.